Tactile Systems Technology
Market Cap
US$979.0m
Last Updated
2021/01/19 00:39 UTC
Data Sources
Company Financials +
Executive Summary
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for chronic diseases in the United States. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with high growth potential.
Share Price & News
How has Tactile Systems Technology's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TCMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: TCMD's weekly volatility (8%) has been stable over the past year.
Market Performance
7 Day Return
-0.8%
TCMD
-1.5%
US Medical Equipment
-1.0%
US Market
1 Year Return
-17.1%
TCMD
20.0%
US Medical Equipment
19.6%
US Market
Return vs Industry: TCMD underperformed the US Medical Equipment industry which returned 20% over the past year.
Return vs Market: TCMD underperformed the US Market which returned 19.6% over the past year.
Shareholder returns
| TCMD | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.8% | -1.5% | -1.0% |
| 30 Day | 27.3% | 2.7% | 2.3% |
| 90 Day | 39.7% | 8.8% | 13.1% |
| 1 Year | -17.1%-17.1% | 21.0%20.0% | 22.3%19.6% |
| 3 Year | 63.8%63.8% | 71.3%67.0% | 45.3%35.7% |
| 5 Year | n/a | 166.8%146.9% | 124.8%99.8% |
Long-Term Price Volatility Vs. Market
How volatile is Tactile Systems Technology's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
Can You Imagine How Tactile Systems Technology's (NASDAQ:TCMD) Shareholders Feel About The 44% Share Price Increase?2 months ago | Simply Wall St
Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next2 months ago | Simply Wall St
Is Tactile Systems Technology (NASDAQ:TCMD) Likely To Turn Things Around?Valuation
Is Tactile Systems Technology undervalued compared to its fair value and its price relative to the market?
8.97x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate TCMD's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate TCMD's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: TCMD is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: TCMD is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TCMD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TCMD is overvalued based on its PB Ratio (9x) compared to the US Medical Equipment industry average (5.1x).
Next Steps
Future Growth
How is Tactile Systems Technology forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
85.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TCMD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: TCMD is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TCMD's is expected to become profitable in the next 3 years.
Revenue vs Market: TCMD's revenue (20% per year) is forecast to grow faster than the US market (10.3% per year).
High Growth Revenue: TCMD's revenue (20% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TCMD's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Tactile Systems Technology performed over the past 5 years?
10.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TCMD is currently unprofitable.
Growing Profit Margin: TCMD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TCMD is unprofitable, but has reduced losses over the past 5 years at a rate of 10.4% per year.
Accelerating Growth: Unable to compare TCMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TCMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.3%).
Return on Equity
High ROE: TCMD has a negative Return on Equity (-7.74%), as it is currently unprofitable.
Next Steps
Financial Health
How is Tactile Systems Technology's financial position?
Financial Position Analysis
Short Term Liabilities: TCMD's short term assets ($114.1M) exceed its short term liabilities ($25.6M).
Long Term Liabilities: TCMD's short term assets ($114.1M) exceed its long term liabilities ($23.0M).
Debt to Equity History and Analysis
Debt Level: TCMD is debt free.
Reducing Debt: TCMD has no debt compared to 5 years ago when its debt to equity ratio was 0.02%.
Debt Coverage: TCMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TCMD has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is Tactile Systems Technology current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TCMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TCMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TCMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TCMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TCMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.4yrs
Average management tenure
CEO
Dan Reuvers (57 yo)
0.58
Tenure
Mr. Daniel L. Reuvers, also known as Dan, has been President, Chief Executive Officer and Director of Tactile Systems Technology, Inc. since June 8, 2020. He served as Executive Vice President and Presiden...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 2.33yrs | US$905.57k | 0.018% $ 171.9k | |
| Senior Vice President of Sales | 13yrs | US$957.57k | 0.092% $ 899.5k | |
| Consultant | 0.58yr | US$2.81m | 1.51% $ 14.8m | |
| President | 0.58yr | no data | no data | |
| Chief Information Officer | 2yrs | no data | no data | |
| VP & Compliance Officer | no data | no data | no data | |
| Vice President of Marketing & Clinical Affairs | 7yrs | no data | no data | |
| Chief Human Resources Officer | 2.42yrs | no data | no data | |
| Chief Medical Officer | 3.5yrs | no data | no data |
2.4yrs
Average Tenure
58.5yo
Average Age
Experienced Management: TCMD's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 0.58yr | no data | no data | |
| Independent Director | 8.33yrs | US$189.98k | 0.54% $ 5.3m | |
| Independent Director | 3.33yrs | US$177.48k | 0.013% $ 131.9k | |
| Independent Director | 5.33yrs | US$189.98k | 0.016% $ 159.8k | |
| Independent Chairman | 8yrs | US$219.98k | 0.57% $ 5.6m | |
| Independent Director | 16.25yrs | US$184.98k | 0.17% $ 1.7m | |
| Member of Vascular Scientific Advisory Board | no data | no data | no data | |
| Member of Vascular Scientific Advisory Board | no data | no data | no data | |
| Chairman of Vascular Scientific Advisory Board | no data | no data | no data | |
| Member of Head & Neck Scientific Advisory Board | no data | no data | no data | |
| Member of Vascular Scientific Advisory Board | no data | no data | no data | |
| Member of the Head & Neck Scientific Advisory Board | no data | no data | no data |
6.7yrs
Average Tenure
65yo
Average Age
Experienced Board: TCMD's board of directors are considered experienced (6.7 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.1%.
Top Shareholders
Company Information
Tactile Systems Technology, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Tactile Systems Technology, Inc.
- Ticker: TCMD
- Exchange: NasdaqGM
- Founded: 1995
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$979.004m
- Shares outstanding: 19.42m
- Website: https://www.tactilemedical.com
Number of Employees
Location
- Tactile Systems Technology, Inc.
- 3701 Wayzata Boulevard
- Suite 300
- Minneapolis
- Minnesota
- 55416
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| TCMD | NasdaqGM (Nasdaq Global Market) | Yes | Common Stock | US | USD | Jul 2016 |
| 3L3 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jul 2016 |
Biography
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compr...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/19 00:39 |
| End of Day Share Price | 2021/01/15 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.